• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCORE模型低估了高血压患者的心血管风险:波兰高血压登记研究结果

SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry.

作者信息

Szyndler Anna, Kucharska Wies Awa, Dubiela-D Browska And Elina, Olszanecka Agnieszka, Widecka Justyna, B Czkiewicz Miros Awa, Widecka Katarzyna, Galas Gra Yna, Chlebi Ska Iwona, Sakiewicz Wojciech, Gaciong Zbigniew, Widecka Krystyna, Januszewicz Andrzej, Kawecka-Jaszcz Kalina, Narkiewicz Krzysztof

机构信息

Hypertension Unit, Dept. Hypertension and Diabetology, Medical University of Gdansk, Poland.

出版信息

Blood Press. 2011 Dec;20(6):342-7. doi: 10.3109/08037051.2011.587267. Epub 2011 Jun 15.

DOI:10.3109/08037051.2011.587267
PMID:21675828
Abstract

OBJECTIVE. The aim of the present study was to compare the effectiveness of Systemic COronary Risk Evaluation (SCORE) charts and European Society of Hypertension/European Society of Cardiology (ESH/ESC) hypertension guidelines for identifying high-risk hypertensive patients. METHODS. The data on hypertensive patients was collected using the Polish Hypertension Registry. We enrolled 636 patients (357 females and 279 males, mean age 54.4 (+/-) 7.9 years) from hypertension centres in Poland. RESULTS. Only 3.5% of the subjects had no additional risk factors. Thirty-six per cent of the patients had three or more risk factors. Metabolic syndrome was found in 40.1% of the patients. According to the SCORE charts, 9.0% of females and 27.2% of males had high to very high cardiovascular risk (p < 0.001). Taking into account risk factors and the metabolic syndrome, 55.7% of females and 56.3% of males (p = NS) had high or very high additional cardiovascular risk according to the 2007 ESH/ESC guidelines. For both females and males, the prevalence of high to very high risk was greater (p < 0.001) from the calculation based on the 2007 ESH/ESC guidelines than from the SCORE charts. Fifty-two per cent of patients classified as low to moderate risk according to the SCORE system, had high or very high risk according to the 2007 ESH/ESC guidelines. CONCLUSIONS. The SCORE charts seem to underestimate the burden of the cardiovascular risk among hypertensive patients. The cardiovascular risk, especially in the hypertensive female population, seems to be much higher when estimated according to the 2007 ESH/ESC guidelines.

摘要

目的。本研究的目的是比较系统性冠状动脉风险评估(SCORE)图表与欧洲高血压学会/欧洲心脏病学会(ESH/ESC)高血压指南在识别高危高血压患者方面的有效性。方法。使用波兰高血压登记处收集高血压患者的数据。我们从波兰的高血压中心招募了636名患者(357名女性和279名男性,平均年龄54.4(±)7.9岁)。结果。只有3.5%的受试者没有其他风险因素。36%的患者有三个或更多风险因素。40.1%的患者存在代谢综合征。根据SCORE图表,9.0%的女性和27.2%的男性有高至非常高的心血管风险(p<0.001)。根据2007年ESH/ESC指南,考虑到风险因素和代谢综合征,55.7%的女性和56.3%的男性(p=无显著性差异)有高或非常高的额外心血管风险。对于女性和男性,根据2007年ESH/ESC指南计算的高至非常高风险的患病率均高于SCORE图表(p<0.001)。根据SCORE系统分类为低至中度风险的患者中,52%根据2007年ESH/ESC指南有高或非常高的风险。结论。SCORE图表似乎低估了高血压患者心血管风险的负担。根据2007年ESH/ESC指南评估时,心血管风险,尤其是在高血压女性人群中,似乎要高得多。

相似文献

1
SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry.SCORE模型低估了高血压患者的心血管风险:波兰高血压登记研究结果
Blood Press. 2011 Dec;20(6):342-7. doi: 10.3109/08037051.2011.587267. Epub 2011 Jun 15.
2
Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.根据2003年欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)指南对单纯原发性高血压患者进行心血管风险分层:与1999年世界卫生组织/国际高血压学会(WHO/ISH)指南标准的比较。
Blood Press. 2004;13(3):144-51. doi: 10.1080/08037050410033169.
3
Cardiovascular risk assessment in hypertensive patients: major discrepancy according to ESH and SCORE strategies.
J Hypertens. 2007 Apr;25(4):757-62. doi: 10.1097/HJH.0b013e328017f6fa.
4
Cardiovascular risk assessment in hypertensive patients with tests recommended by the European Guidelines on Hypertension.高血压患者心血管风险评估——依据欧洲高血压指南推荐的检查。
Eur J Prev Cardiol. 2012 Jun;19(3):515-22. doi: 10.1177/1741826711401981. Epub 2011 Mar 10.
5
Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines.代谢综合征对高血压患者危险分层的影响:2003年与2007年欧洲高血压学会-欧洲心脏病学会指南的差异
Ther Adv Cardiovasc Dis. 2010 Apr;4(2):97-103. doi: 10.1177/1753944709341304. Epub 2010 Mar 3.
6
Usefulness of optic fundus examination with retinography in initial evaluation of hypertensive patients.眼底视网膜造影检查在高血压患者初始评估中的应用价值。
Am J Hypertens. 2008 Apr;21(4):400-5. doi: 10.1038/ajh.2008.3. Epub 2008 Feb 7.
7
Cardiovascular risk profile of young hypertensive patients: the OPENJOVEN study.年轻高血压患者的心血管风险特征:OPENJOVEN 研究。
Eur J Prev Cardiol. 2012 Jun;19(3):534-40. doi: 10.1177/1741826711406202. Epub 2011 Apr 7.
8
[Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].[肾小球滤过率降低作为高血压患者慢性肾脏病的标志物]
Pol Merkur Lekarski. 2008 Jun;24(144):487-91.
9
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
10
Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.欧洲未控制高血压患者中代谢综合征患病率增加:高血压疾病患者全球心血管代谢风险概况调查
J Hypertens. 2008 Oct;26(10):2064-70. doi: 10.1097/HJH.0b013e32830c45c3.

引用本文的文献

1
SCORE and SCORE2 in East Asian Population: A Performance Comparison.东亚人群中的SCORE和SCORE2:性能比较
JACC Asia. 2023 Dec 26;4(4):265-274. doi: 10.1016/j.jacasi.2023.10.013. eCollection 2024 Apr.
2
Do patients or their physicians more accurately assess long-term risk associated with hypertension? A population-based study.患者或其医生对与高血压相关的长期风险评估更准确?一项基于人群的研究。
Scand J Prim Health Care. 2020 Jun;38(2):166-175. doi: 10.1080/02813432.2020.1753345. Epub 2020 May 2.
3
New insights into the management of hypertension and cardiovascular risk with Angiotensin receptor blockers: observational studies help us?
血管紧张素受体阻滞剂在高血压及心血管风险管理方面的新见解:观察性研究对我们有帮助吗?
Open Cardiovasc Med J. 2014 Apr 4;8:35-42. doi: 10.2174/1874192401408010035. eCollection 2014.